Zhengye Biotechnology Holding (ZYBT) Equity Ratio: 2023-2024
Historic Equity Ratio for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to 0.70.
- Zhengye Biotechnology Holding's Equity Ratio rose 5.31% to 0.71 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.71, marking a year-over-year increase of 5.31%. This contributed to the annual value of 0.70 for FY2024, which is 3.67% up from last year.
- According to the latest figures from FY2024, Zhengye Biotechnology Holding's Equity Ratio is 0.70, which was up 3.67% from 0.68 recorded in FY2023.
- Zhengye Biotechnology Holding's 5-year Equity Ratio high stood at 0.70 for FY2024, and its period low was 0.68 during FY2023.
- Over the past 2 years, Zhengye Biotechnology Holding's median Equity Ratio value was 0.69 (recorded in 2023), while the average stood at 0.69.
- Data for Zhengye Biotechnology Holding's Equity Ratio shows a peak YoY grew of 3.67% (in 2024) over the last 5 years.
- Zhengye Biotechnology Holding's Equity Ratio (Yearly) stood at 0.68 in 2023, then rose by 3.67% to 0.70 in 2024.